{"entity":{"id":"changchun-genescience","kind":"company","name":"Changchun GeneScience Pharmaceutical","aka":["Changchun GeneScience Pharmaceutical Co., Ltd.","GeneScience","GenSci","长春金赛药业"],"tldr":"GeneScience is a Changchun biotech known for growth hormone that also makes a long-acting G-CSF used to prevent infection after chemotherapy, and leads phase 3 cancer trials in China.","summary":"Changchun GeneScience Pharmaceutical (GenSci), based in Changchun in north-east China, is a biopharmaceutical company best known for recombinant human growth hormone. Its oncology products include a pegylated granulocyte colony-stimulating factor for chemotherapy-induced neutropenia, and it is lead sponsor of phase 3 cancer trials registered on ClinicalTrials.gov.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.gensci-china.com"},{"label":"ClinicalTrials.gov: trials led by Changchun GeneScience Pharmaceutical","url":"https://clinicaltrials.gov/search?lead=Changchun%20GeneScience%20Pharmaceutical"}],"tags":["ctgov-sponsor"],"related":[],"cancers":[],"sections":["supportive-care"],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["neutropenia"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Changchun","country":"CN","companyType":"biotech","website":"https://www.gensci-china.com","stage":"public","investors":[],"funding":[]},"route":"/companies/changchun-genescience/","neighbours":{"section":[{"id":"supportive-care","kind":"section","name":"Supportive Care & Survivorship","route":"/fronts/supportive-care/"}],"term":[{"id":"neutropenia","kind":"term","name":"Neutropenia","route":"/terms/neutropenia/"}]}}